Open Heart

MARCH 13, 2025

Mediation analyses were performed to assess the proportion mediated by MDD. Results Genetically predicted insomnia, short sleep, daytime napping and daytime sleepiness increased the risk of CVDs, with the OR ranging from 1.24 (95% CI 1.06 to 1.45) for insomnia on stroke to 1.55 (95% CI 1.28 to 1.89) for insomnia on MI.

Cardiovascular Disease 52

Cardiovascular Disease Coronary Artery Disease Myocardial Infarction Atrial Fibrillation 52

Journal of the American Heart Association

JANUARY 23, 2025

Hemodynamic reactivity, changes in endothelial function, and vasoconstriction during mental stress were evaluated using changes in ratepressure product, brachial artery flowmediated vasodilation, and peripheral arterial tonometry, respectively. A total of 629 participants were included.

Coronary Artery Disease 56

Coronary Artery Disease Outcomes Myocardial Infarction Risk Factors 56

Circulation: Cardiovascular Imaging

NOVEMBER 30, 2023

Circulation: Cardiovascular Imaging, Ahead of Print.

Coronary Artery Disease 72

Coronary Artery Disease Myocardial Infarction Cardiovascular Imaging Embolism 72

Dr. Paddy Barrett

APRIL 5, 2024

A common feedback I get is that people with existing coronary artery disease feel like it doesn’t apply to them. Arguably, applying the principles of prevention offers more bang for buck in the short term for people WITH coronary artery disease than those without coronary artery disease.

Heart Disease 118

Heart Disease Coronary Artery Disease Heart attacks Heart Attack 118

Journal of Cardiovascular Pharmacology

NOVEMBER 11, 2024

Patients with ST-segment elevation myocardial infarction (STEMI) and complex coronary artery disease (CAD) face a poor prognosis, including increased heart failure (HF) risk.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Heart Failure 40

Frontiers in Cardiovascular Medicine

FEBRUARY 12, 2024

Introduction Coronary artery disease (CAD) is a highly heritable and multifactorial disease. Numerous genome-wide association studies (GWAS) facilitated the construction of polygenic risk scores (PRS) for predicting future incidence of CAD, however, exclusively in European populations.

Coronary Artery Disease 59

Coronary Artery Disease Risk Factors Cholesterol Myocardial Infarction 59

Circulation

NOVEMBER 11, 2024

A random-effects model was used for outcomes with high heterogeneity.Results:We included 4 RCTs with 3173 patients comparing FFR-guided CR with culprit-only PCI in patients with STEMI and multivessel coronary artery diseases. The pooled results of the 4 RCTs showed that MACE (RR=0.66; 95% CI [0.45, 0.99]; p=0.01; 16.8%

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction STEMI Thrombosis 40

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2024

We investigated whether treatment with LDE-paclitaxel changes plaque progression by coronary CT angiography and is safe in patients with chronic coronary artery disease. Analysis of inflammatory biomarkers and coronary CTA was also performed at baseline and 4 weeks after treatment.

Coronary Artery Disease 59

Coronary Artery Disease Laboratory Plaque Myocardial Infarction 59

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

ObjectivesRevascularization in patients with severely reduced left ventricular function and coronary artery disease (CAD) is associated with a high perioperative risk.

Coronary Artery Bypass Graft 59

Coronary Artery Bypass Graft Coronary Artery Disease Heart Failure Myocardial Infarction 59

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

Med Page Today

APRIL 10, 2024

(MedPage Today) -- ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in better outcomes compared.

Coronary Artery Disease 65

Coronary Artery Disease Myocardial Infarction Outcomes STEMI 65

American College of Cardiology

JULY 10, 2024

What is the outcome of contemporary revascularization strategies in patients presenting with myocardial infarction (MI) and multivessel coronary artery disease (CAD)?

Coronary Artery Disease 63

Coronary Artery Disease Myocardial Infarction Outcomes Article 63

Medical Xpress - ECG

JUNE 6, 2023

Coronary computed tomography angiography (CCTA) is associated with a similar risk for cardiovascular death and myocardial infarction as direct invasive coronary angiography (ICA) for initial assessment of suspected stable coronary artery disease (CAD), according to a review published online June 6 in the Annals of Internal Medicine.

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction 40

Journal of the American Heart Association

DECEMBER 24, 2024

BackgroundRisk stratification of patients with symptomatic nonobstructive coronary artery disease remains uncertain. in all 3 coronary arteries on coronary angiography. Journal of the American Heart Association, Ahead of Print. A total of 490 patients were included.

Coronary Artery Disease 45

Coronary Artery Disease Myocardial Infarction Stenosis 45

Journal of the American Heart Association

MARCH 27, 2025

BackgroundRecent evidence highlights an increasing incidence of myocardial infarction in young women. years]) admitted to the China Chest Pain Center Database between 2016 and 2021.

Myocardial Infarction 40

Myocardial Infarction Peripheral Arterial Disease Outcomes Chest Pain 40

Heart BMJ

DECEMBER 13, 2024

Background The diagnostic performance of non-invasive imaging techniques for detecting obstructive coronary artery disease (CAD) in patients with a history of myocardial infarction or percutaneous coronary intervention has not been comprehensively evaluated.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction 52

Cardiology Update

MARCH 25, 2024

Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. However, the comparative long-term efficacy of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with these conditions remains unclear.

Diabetes 122

Diabetes Coronary Artery Bypass Graft Outcomes Coronary Artery Disease 122

Open Heart

OCTOBER 1, 2024

Background The prognosis of myocardial ischaemia with no obstructive coronary artery disease (INOCA) and its underlying vasomotor disorders, vasospastic angina (VSA) and microvascular angina (MVA), is not well defined.

Coronary Artery Disease 52

Coronary Artery Disease Outcomes Angina Myocardial Infarction 52

Circulation: Cardiovascular Quality & Outcomes

NOVEMBER 20, 2024

We investigated whether PTSD was independently associated with first and recurrent heart failure hospitalizations in the setting of coronary artery disease.METHODS:Individuals with stable coronary artery disease and without heart failure at baseline were enrolled in 2 parallel prospective cohort studies in metropolitan Atlanta, GA.

Coronary Artery Disease 40

Coronary Artery Disease Heart Failure Hospital Myocardial Infarction 40

American College of Cardiology

MAY 24, 2024

The goal of the FIRE trial was to evaluate multivessel revascularization guided by coronary physiology compared with culprit-only revascularization among elderly patients with acute myocardial infarction (MI) and multivessel coronary artery disease (CAD).

Coronary Artery Disease 60

Coronary Artery Disease Myocardial Infarction Physiology Article 60

American College of Cardiology

APRIL 7, 2024

Long-term treatment with beta-blockers may not lower the risk of death or myocardial infarction (MI) in patients with MI, a preserved left ventricular ejection fraction (LVEF) of ≥50% and coronary artery disease, according to the results of the REDUCE-AMI study, presented during a Late-Breaking Clinical Trial session at ACC.24

Coronary Artery Disease 65

Coronary Artery Disease Myocardial Infarction Article 65

The New England Journal of Medicine

APRIL 6, 2024

The benefit of beta-blockers after myocardial infarction was established before the advent of reperfusion and percutaneous coronary intervention and the availability of effective secondary preventive medications.1-3

Myocardial Infarction 56

Myocardial Infarction Coronary Artery Disease 56

Coronary Artery Disease Journal

SEPTEMBER 24, 2024

Introduction Despite advancements in coronary artery disease (CAD) management, major adverse cardiovascular events persist. Primary outcomes included myocardial infarction, stroke, major bleeding events, and all-cause mortality. 0.95; P = 0.002), myocardial infarction (HR, 0.81; 95% CI, 0.70–0.94;

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Stroke Strokes 40

Frontiers in Cardiovascular Medicine

OCTOBER 7, 2024

BackgroundIn Thailand, access to specific pharmaceuticals and medical devices for ST-elevation myocardial infarction (STEMI) patients is restricted within certain healthcare systems, leading to inequalities in the quality of medical care among different healthcare systems.

Public Health 52

Public Health Myocardial Infarction STEMI Coronary Artery Disease 52

Open Heart

MARCH 28, 2025

The presence of atrial arrhythmias during stress testing at all time points was also associated with later diagnosis of coronary artery disease or myocardial infarction: OR 1.82 (95% CI 1.09, 3.03), p=0.02. However, it is linked to subsequent diagnosis of AF, coronary artery disease and myocardial infarction.

52

52

Coronary Artery Disease Journal

OCTOBER 23, 2023

Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. Methods Data from the 2020 California State Inpatient Database was used retrospectively.

COVID-19 52

COVID-19 Myocardial Infarction Hospital ICU 52

Open Heart

JUNE 21, 2022

Background Several studies have demonstrated that complete revascularisation improves clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease. However, the optimal timing of non-culprit lesion revascularisation remains controversial.

Myocardial Infarction 52

Myocardial Infarction STEMI Coronary Artery Disease Outcomes 52

Heart BMJ

JANUARY 10, 2024

Myocardial infarction with non-obstructive coronary arteries (MINOCA) defines a heterogeneous group of atherosclerotic and non-atherosclerotic conditions, causing myocardial injury in the absence of obstructive coronary artery disease.

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Disease Ultrasound Plaque 40

Coronary Artery Disease Journal

MARCH 27, 2024

No abstract available

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction 40

Nature Reviews - Cardiology

MAY 6, 2024

Nature Reviews Cardiology, Published online: 07 May 2024; doi:10.1038/s41569-024-01014-0 In 1993, Lincoff and Topol claimed that the thrombolytic treatment of ST-segment elevation myocardial infarction was suboptimal in many patients and gave an ‘illusion of reperfusion’.

Coronary Artery Disease 59

Coronary Artery Disease Myocardial Infarction Article Outcomes 59

Coronary Artery Disease Journal

OCTOBER 30, 2023

Introduction Elevated peak cardiac troponin levels have been linked with increased morbidity and mortality in patients with acute myocardial infarction (AMI). Immature Platelets are young and relatively large platelets that are hyper-reactive and pro-thrombotic compared to regular platelets.

Myocardial Infarction 52

Myocardial Infarction STEMI 52

Journal of the American Heart Association

JANUARY 10, 2025

The secondary outcome was death or nonfatal myocardial infarction. Predictive abilities for outcomes were compared among 3 models (model 1, constructed using clinical variables; model 2, model 1+coronary computed tomography angiographyderived anatomical parameters; and model 3, model 2+CTFFR).

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Outcomes 40

Med Page Today

APRIL 8, 2024

(MedPage Today) -- ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other cardiovascular risk factors, the.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction Risk Factors Outcomes 52

Med Page Today

JULY 9, 2024

(MedPage Today) -- The latest evidence moves the needle closer in favor of one-go complete revascularization for people with acute myocardial infarction (MI) and multivessel coronary artery disease, according to an updated network meta-analysis.

Coronary Artery Disease 52

Coronary Artery Disease Myocardial Infarction 52

Open Heart

AUGUST 21, 2023

Background Insights on the differences in clinical outcomes, quality of life (QoL) and health resource utilisation (HRU) with different levels of care available to post-acute myocardial infarction (AMI) populations in rural and urban settings are limited.

Myocardial Infarction 52

Myocardial Infarction Angina Outcomes Coronary Artery Disease 52

Circulation

NOVEMBER 11, 2024

Background:Myocardial infarction with nonobstructive coronary artery disease (MINOCA) is a special syndrome with clear evidence of myocardial ischemia, but no clear stenosis of coronary artery imaging sign. Circulation, Volume 150, Issue Suppl_1 , Page A4143007-A4143007, November 12, 2024.

Coronary Artery Disease 40

Coronary Artery Disease Atrial Fibrillation Myocardial Infarction Ischemia 40

Journal of the American Heart Association

DECEMBER 1, 2023

BackgroundCoronary computed tomography angiography is increasingly used as the first‐line test for suspected coronary artery disease. The overall mortality, cardiac deaths, myocardial infarctions, and hospitalizations for unstable angina were acquired from national registry data for 1 to 10 years of follow‐up (median, 4 years).

Coronary Artery Disease 40

Coronary Artery Disease Myocardial Infarction Angina Hospital 40